Featured news
-
You Made a Difference - Team Award - June 2025
This month’s You Made a Difference team award goes to the NCCU team, who have demonstrated extraordinary compassion, professionalism and teamwork in supporting one of their long-term patients through the final stages of her life.
-
Vasculitis team holds second training course
A second three-day course for nurses managing patients with a rare condition called vasculitis is to be held at Addenbrooke’s Hospital.
-
Addenbrooke’s to gain innovative full-body scanner supporting national research
The new total-body PET scanner is expected in late 2026. It provides a faster, safer way to get detailed full-body images for diagnosis, treatment and research of complex diseases.
-
Study prompts global call on pituitary tumour research
Brain surgeons and researchers from Cambridge and London are calling on colleagues worldwide to adopt the first ever consistent way of recording outcomes following pituitary gland tumour removal.
-
Pioneering breast cancer programme opens in more hospitals across the East
Patients who join the Personalised Breast Cancer Programme, which was pioneered at Addenbrooke's Hospital in Cambridge, have their DNA read like a barcode, with the whole genome of their tumour sequenced and the results returned to inform treatment.
-
Life-saving test identifies pneumonia causing microbes
Groundbreaking work by Addenbrooke’s John Farman Intensive Care Unit (ICU) and other Cambridge partners to treat critically ill patients with life-threatening pneumonia is taking a huge leap forwards
All news
Showing 20 results
Neurosurgeon Hutch gains top post
Professor Peter Hutchinson, Professor of Neurosurgery and Consultant neurosurgeon in Cambridge, has been appointed as president of the Society of British Neurological Surgeons– stressing the honour recognises the work of all his colleagues.
More patients in the East to benefit from personalised breast cancer treatment
A ground-breaking breast cancer programme pioneered at Addenbrooke’s Hospital, which decodes the genetic sequence of a patient’s cancer is to expand in the East.
New lab to open to make cutting-edge CAR-T cells in Cambridge
A new state-of-the-art laboratory is set to open at Addenbrooke’s Hospital that will deliver ‘home-grown’ CAR-T cells to help improve treatment for blood cancers.
Patients welcome £173m funding announcement to study cancer
As Cambridge scientists at the Cancer Research UK Cambridge Institute receive a £173m investment to help study cancer, Fiona Carey, Co-Chair of the Patient Advisory Group for Cambridge Cancer Research Hospital, welcomes the announcement and says patients must be at the centre of cancer research.
You Made a Difference - July 2024
A consultant in general surgery who is a pillar of support and inspiration and a clinical technician who has given a voice back to patients often feeling on the edges of family are our winners of the July You Made a Difference awards.
Research sets global standard for Crohn’s treatment
Trial results published by Cambridge researchers earlier this year and involving patients at Addenbrooke’s Hospital are helping to set new global standards for the treatment of Crohn’s disease, it has emerged
Survivor David backs ‘Restart a Heart’ campaign
A devoted Cambridge United fan who received life-saving treatment at a packed home match has today applauded a month-long initiative aimed at teaching the public CPR – officially called cardiopulmonary resuscitation.
Genetic screening for newborns begins at CUH
Dozens of newborn babies at the Rosie Hospital have begun to be tested for over 200 rare genetic conditions as part of a world-leading study.
Trust is first to achieve technology award under new criteria
Cambridge University Hospitals NHS Foundation Trust (CUH) has become the first healthcare trust in the UK to revalidate against the highest international quality standard that recognises the use of technology, data and analytics, and patient engagement and involvement to support the delivery of high-quality patient care.
Cambridge Cancer Research Hospital continues to make progress
On Friday 20th September 2024, the Government published the terms of reference for the New Hospital Programme (NHP) review. As the Cambridge Cancer Research Hospital project does not yet have full business case approval, we will be included in the national review, which aims to put the NHP on a deliverable timetable.
CUH plays key role in international cancer studies
The biggest cancer conference in Europe heard how Cambridge University Hospitals’ clinicians, patients and sponsors are playing key roles in two multi-centre international studies that could help shape future care.
Cambridge mum gives birth to first baby in pre-eclampsia study
A mum from Cambridge has become the first person to give birth while taking part in POPPY, a pregnancy research study at Addenbrooke's examining why pre-eclampsia and placental complications can occur during pregnancy.
Hospital prosthetics service moves to high-tech new home
An Addenbrooke’s service that offers vital support for amputees and others today (23 Sept) officially opened at a high-tech new home after nearly quarter of a century at the hospital.
New state-of-the-art radiotherapy equipment benefiting patients in the East
Cancer patients are benefiting from a new type of radiotherapy which reduces treatment time whilst increasing accuracy and patient comfort.
Team’s hip replacement surgery invention is set to be world first
Technology which is the first of its kind in the world and could transform the future of hip replacement surgery is being pioneered by a team of experts in Cambridge.
Community programme working to improve care for children with asthma
A team of specialist asthma practitioners in Cambridgeshire are working together to address health inequalities and improve outcomes for children and young people with asthma.
Trauma conference gripped by moving stories
More than 700 guests from 52 countries descended on Cambridge yesterday (Wednesday 4 Sept) for a public symposium that was part of a week-long series of events organised as part of the 2024 meeting of the International Trauma Society (INTS).
Team praised for “game-changing” heart trial
A senior Addenbrooke’s early phase trials researcher has praised patients, staff and sponsors who backed a landmark trial which could be a “game changer” in the battle to prevent repeat heart attacks.
New nature design for MRI scanner helps calm patients
For the first time in the UK, an MRI scanner has been wrapped in vinyl with nature-inspired artwork to help calm patients.
Cambridgeshire boy takes part in brain tumour drug trial
A Cambridgeshire boy who is living with an inoperable brain tumour is taking part in a global clinical trial, comparing an investigational treatment to standard chemotherapy. This comes days after plans for Cambridge Children's Hospital, with its 5000sqm research institute, were given the go ahead by government.